1. Home
  2. Lymphogranuloma venereum - Annual Epidemiological Report for 2023

Lymphogranuloma venereum - Annual Epidemiological Report for 2023

Surveillance and monitoring
Publication series: Annual Epidemiological Report
Time period covered: This report is based on data for 2023 retrieved from The European Surveillance System (TESSy) on 31 October 2024.
Cite:

European Centre for Disease Prevention and Control. Lymphogranuloma venereum. In: ECDC. Annual epidemiological report for 2023. Stockholm: ECDC; 2025.
Take our survey
Share your feedback in our short survey and help us improve publications at ECDC. Your input is valuable!

Lymphogranuloma venereum (LGV) is a systemic sexually transmitted infection (STI) caused by Chlamydia trachomatis serovars L1, L2, or L3.

Executive summary

• In 2023, 22 EU/EEA countries reported 3 075 cases of LGV, an increase of 41% compared with 2022.
• Two countries (the Netherlands and Spain) accounted for 77% of all notified cases.
• Almost all cases in 2023 were reported among men who have sex with men; among cases with known HIV status, 38% were HIV positive.
• Between 2019 and 2023, the proportion of LGV cases with HIV-negative status has increased from 56% in 2019 to 63% in 2023.

Download

Cover for AERS
Lymphogranuloma venereum - Annual Epidemiological Report for 2023 - EN - [PDF-539.15 KB]